Evidence map›Paper›PMID 19096501›Full record

ArticlePLoS computational biology2008

Malleable machines in transcription regulation: the mediator complex.

Agnes Tóth-Petróczy, Christopher J Oldfield, István Simon, Yuichiro Takagi, A Keith Dunker, Vladimir N Uversky, Monika Fuxreiter

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 135 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Liquid condensates: a new barrier to loop extrusion?Cellular and molecular life sciences : CMLS · 2025
    Review
  6. Article
  7. Accurate and Fast Prediction of Intrinsic Disorder Using flDPnn.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Transcription Factor Dynamics.Cold Spring Harbor perspectives in biology · 2021
    Review
  17. Article
  18. MedProDB: A database of Mediator proteins.Computational and structural biotechnology journal · 2021
    Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Agnes Tóth-PetróczyInstitute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Budapest, Hungary.
Christopher J Oldfield
István Simon
Yuichiro Takagi
A Keith Dunker
Vladimir N Uversky
Monika Fuxreiter
Hungarian Academy of Sciences · HUIndiana University – Purdue University Indianapolis · USIndiana University School of MedicineInstitute for Biological Instrumentation · RUInstitute of Molecular Life Sciences · HU

Funding

Bioinformatics linkage of protein disorder and functionR01LM007688 · NLM · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI DUNKER, ALAN KEITH · 2003 to 2006
$1.3M
Mining the Structural Genomics Initiative for DisorderR01GM071714 · NIGMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI DUNKER, ALAN KEITH · 2006 to 2009
$1.1M
NIGMS NIH HHS GM071714-01A2NIGMS NIH HHS R01 GM071714NLM NIH HHS R01 LM007688NLM NIH HHS R01 LM007688-01A1
6 · The paper itself

Abstract

The Mediator complex provides an interface between gene-specific regulatory proteins and the general transcription machinery including RNA polymerase II (RNAP II). The complex has a modular architecture (Head, Middle, and Tail) and cryoelectron microscopy analysis suggested that it undergoes dramatic conformational changes upon interactions with activators and RNAP II. These rearrangements have been proposed to play a role in the assembly of the preinitiation complex and also to contribute to the regulatory mechanism of Mediator. In analogy to many regulatory and transcriptional proteins, we reasoned that Mediator might also utilize intrinsically disordered regions (IDRs) to facilitate structural transitions and transmit transcriptional signals. Indeed, a high prevalence of IDRs was found in various subunits of Mediator from both Saccharomyces cerevisiae and Homo sapiens, especially in the Tail and the Middle modules. The level of disorder increases from yeast to man, although in both organisms it significantly exceeds that of multiprotein complexes of a similar size. IDRs can contribute to Mediator's function in three different ways: they can individually serve as target sites for multiple partners having distinctive structures; they can act as malleable linkers connecting globular domains that impart modular functionality on the complex; and they can also facilitate assembly and disassembly of complexes in response to regulatory signals. Short segments of IDRs, termed molecular recognition features (MoRFs) distinguished by a high protein-protein interaction propensity, were identified in 16 and 19 subunits of the yeast and human Mediator, respectively. In Saccharomyces cerevisiae, the functional roles of 11 MoRFs have been experimentally verified, and those in the Med8/Med18/Med20 and Med7/Med21 complexes were structurally confirmed. Although the Saccharomyces cerevisiae and Homo sapiens Mediator sequences are only weakly conserved, the arrangements of the disordered regions and their embedded interaction sites are quite similar in the two organisms. All of these data suggest an integral role for intrinsic disorder in Mediator's function.

Indexed as

Models, GeneticComputer SimulationGene Expression RegulationTrans-ActivatorsTranscriptional ActivationTranscription FactorsTrans-ActivatorsTranscription Factors

Identifiers

PMID19096501
PMCPMC2588115
OpenAlexW2030617121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.